jsmsJournal of Siberian Medical SciencesJournal of Siberian Medical Sciences2542-1174Federal state budgetary educational institution of higher education "Novosibirsk state medical university" of Ministry of Health of the Russian Federation (FSBEI HE NSMU MOH Russia)10.31549/2542-1174-2024-8-2-114-126jsms-1051Research ArticleОБЗОРREVIEWАссоциация новой коронавирусной инфекции COVID-19 и патологии эндометрия (обзор литературы)Association of the novel coronavirus infection (COVID-19) and endometrial pathology (literature review)https://orcid.org/0000-0002-9245-3749ЗатворницкаяА. В.ZatvornitskayaA. V.

Затворницкая Александра Вадимовна – канд. мед. наук, ассистент кафедры патологической анатомии и судебной медицины им. профессора В.Л. Коваленко

454092, г. Челябинск, ул. Вороского, 64

Aleksandra V. Zatvornitskaya – Cand. Sci. (Med.), Assistant, Department of Pathological Anatomy and Forensic Medicine named after Professor V.L. Kovalenko

Chelyabinsk

monostyle@list.ruhttps://orcid.org/0000-0002-2008-7671КазачковЕ. Л.KazachkovE. L.

Казачков Евгений Леонидович – д-р мед. наук, профессор, заведующий кафедрой патологической анатомии и судебной медицины им. профессора В.Л. Коваленко

Челябинск

Evgeniy L. Kazachkov – Dr. Sci. (Med.), Professor, Head, Department of Pathological Anatomy and Forensic Medicine named after Professor V.L. Kovalenko

Chelyabinsk

https://orcid.org/0000-0002-1175-4479КазачковаЭ. А.KazachkovaE. A.

Казачкова Элла Алексеевна – д-р мед. наук, профессор кафедры акушерства и гинекологии

Челябинск

Ella A. Kazachkova – Dr. Sci. (Med.), Professor, Department of Obstetrics and Gynecology

Chelyabinsk

https://orcid.org/0000-0003-0800-3380ВоропаеваЕ. Е.VoropaevaE. E.

Воропаева Екатерина Евгеньевна – д-р мед. наук, профессор кафедры патологической анатомии и судебной медицины им. профессора В.Л. Коваленко

Челябинск

Ekaterina E. Voropaeva – Dr. Sci. (Med.), Professor, Department of Pathological Anatomy and Forensic Medicine named after Professor V.L. Kovalenko

Chelyabinsk

ФГБОУ ВО «Южно-Уральский государственный медицинский университет»РоссияSouth Ural State Medical UniversityRussian Federation20242306202482114126Copyright © Затворницкая А.В., Казачков Е.Л., Казачкова Э.А., Воропаева Е.Е., 20242024Затворницкая А.В., Казачков Е.Л., Казачкова Э.А., Воропаева Е.Е.Zatvornitskaya A.V., Kazachkov E.L., Kazachkova E.A., Voropaeva E.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://jsms.elpub.ru/jour/article/view/1051

В настоящем обзоре литературы представлены имеющиеся сведения о возможных путях воздействия вируса SARS-CoV-2 и новой коронавирусной инфекции COVID-19 на женскую репродуктивную систему. Описаны вероятные механизмы влияния SARS-CoV-2 на слизистую оболочку матки и возможный вклад вируса в развитие гиперплазии эндометрия.

This literature review presents available information on the possible ways in which the SARS-CoV-2 virus and the novel coronavirus infection (COVID-19) aff ect the female reproductive system. The putative mechanisms of the impact of SARSCoV-2 on the uterine mucosa and the possible contribution of the virus to the development of endometrial hyperplasia are described.

SARS-CoV-2COVID-19эндометрийгиперплазия эндометрияSARS-CoV-2COVID-19endometriumendometrial hyperplasiaReferencesHamming I., Timens W., Bulthuis M.L. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A fi rst step in understanding SARS pathogenesis // J. Pathol. 2004;203(2):631-637. DOI: 10.1002/path.1570.Hamming I., Timens W., Bulthuis M.L. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A fi rst step in understanding SARS pathogenesis. J. Pathol. 2004;203(2):631-637. DOI: 10.1002/path.1570.Hernández A., Papadakos P.J., Torres A. et al. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19 // Rev. Esp. Anestesiol. Reanim. (Engl. Ed.). 2020;67(5):245-252. DOI: 10.1016/j.redar.2020.03.004.Hernández A., Papadakos P.J., Torres A. et al. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev. Esp. Anestesiol. Reanim. (Engl. Ed.). 2020;67(5):245-252. DOI: 10.1016/j.redar.2020.03.004.Vora S.M., Lieberman J., Wu H. Infl ammasome activation at the crux of severe COVID-19 // Nat. Rev. Immunol. 2021;21(11):694-703. DOI: 10.1038/s41577-021-00588-x.Vora S.M., Lieberman J., Wu H. Infl ammasome activation at the crux of severe COVID-19. Nat. Rev. Immunol. 2021;21(11):694-703. DOI: 10.1038/s41577-021-00588-x.Насонов Е.Л. Коронавирусная болезнь 2019 (COVID-19) и аутоиммунитет // Научно-практическая ревматология. 2021;59(1):5-30. DOI: 10.47360/1995-4484-2021-5-30.Nasonov E.L. Coronavirus disease 2019 (COVID-19) and autoimmunity. Rheumatology Science and Practice. 2021;59(1):5-30. DOI: 10.47360/1995-4484-2021-5-30. (In Russ.)Varga Z., Flammer A.J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19 // Lancet. 2020;395(10234):1417–1418. DOI: 10.1016/S0140-6736(20)30937-5Varga Z., Flammer A.J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. DOI: 10.1016/S0140-6736(20)30937-5Щеголев А.И., Туманова У.Н., Серов В.Н. Поражения плаценты у беременных с SARS-CoV-2-инфекцией // Акушерство и гинекология. 2020;12:44-52. DOI: 10.18565/aig.2020.12.44-52Shchegolev A.I., Tumanova U.N., Serov V.N. Placental lesions in pregnant women with SARS-COV-2 infection. Obstetrics and Gynecology. 2020;12:44-52. DOI: 10.18565/aig.2020.12.44-52. (In Russ.)Казачкова Э.А., Хелашвили И.Г., Воропаева Е.Е. и др. Новая коронавирусная инфекция COVID-19 с мультисистемными проявлениями при беременности: трудности дифференциальной диагностики и лечения, перинатальный исход (клиническое наблюдение) // Актуальные вопросы патологоанатомической практики: Материалы VII Всероссийской научно-практической конференции с международным участием, Челябинск, 07–08 апреля 2023 года. Челябинск: ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации, 2023. С. 45–50.Kazachkova E.A., Khelashvili I.G., Voropaeva E.E. et al. (2023). Novel coronavirus infection COVID-19 with multisystem manifestations during pregnancy: diffi culties in diff erential diagnosis and treatment, perinatal outcome (case report). In Current Issues in Pathoanatomical Practice: Materials of the VII All-Russian Scientifi c and Practical Conference with International Participation, Chelyabinsk, April 07–08, 2023. Che lyabinsk, South Ural State Medical University. P. 45–50. (In Russ.)Lambert D.W., Yarski M., Warner F.J. et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2) // J. Biol. Chem. 2005;280(34):30113-30119. DOI: 10.1074/jbc.M505111200.Lambert D.W., Yarski M., Warner F.J. et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 2005;280(34):30113-30119. DOI: 10.1074/jbc.M505111200.Li M.Y., Li L., Zhang Y., Wang X.S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues // Infect. Dis. Poverty. 2020;9(1):45. DOI: 10.1186/s40249-020-00662-x.Li M.Y., Li L., Zhang Y., Wang X.S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020;9(1):45. DOI: 10.1186/s40249-020-00662-x.Medina-Enríquez M.M., Lopez-León S., Carlos-Escalante J.A. et al. ACE2: the molecular doorway to SARS-CoV-2 // Cell Biosci. 2020;10(1):148. DOI:10.1186/s13578-020-00519-8.Medina-Enríquez M.M., Lopez-León S., Carlos-Escalante J.A. et al. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci. 2020;10(1):148. DOI: 10.1186/s13578-020-00519-8.Wu F., Zhao S., Yu B. et al. A new coronavirus associated with human respiratory disease in China // Nature. 2020;579(7798):265-269. DOI: 10.1038/s41586-020-2008-3.Wu F., Zhao S., Yu B. et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269. DOI:10.1038/s41586-020-2008-3.Chan J.F.W., Kok K.H., Zhu Z. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan // Emerg. Microbes Infect. 2020;9(1):221-236. DOI: 10.1080/22221751.2020.1719902Chan J.F.W., Kok K.H., Zhu Z. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9(1):221-236. DOI: 10.1080/22221751.2020.1719902Коган Е.А., Березовский Ю.С., Проценко Д.Д. и др. Патологическая анатомия инфекции, вызванной SARS-CoV-2 // Судебная медицина. 2020;6(2):8-30. DOI: 10.19048/2411-8729-2020-6-2-8-30.Kogan E.A., Berezovsky Yu.S., Protsenko D.D. et al. Pathological anatomy of infection caused by SARS-CoV-2. Russian Journal of Forensic Medicine. 2020;6(2):8-30. DOI: 10.19048/2411-8729-2020-6-2- 8-30. (In Russ.)Yan R., Zhang Y., Li Y. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 // Science. 2020;367(6485):1444-1448. DOI: 10.1126/science.abb2762.Yan R., Zhang Y., Li Y. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444-1448. DOI: 10.1126/science.abb2762.Hoff mann M., Kleine-Weber H., Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor // Cell. 2020; 181(2): 271-280.e8. DOI: 10.1016/j.cell.2020.02.052.Hoff mann M., Kleine-Weber H., Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181(2): 271-280.e8. DOI: 1 0.1016/j.cell.2020.02.052.Долгушин Г.О., Романов А.Ю. Влияние SARS-CoV-2 на репродукцию человека // Акушерство и гинекология. 2020;11:6-12. DOI: 10.18565/aig.2020.ll.6-12.Dolgushin G.O., Romanov A.Yu. Eff ects of SARS-CoV-2 on human reproduction. Obstetrics and Gynecology. 2020;11:6-12. DOI: 10.18565/aig.2020.ll.6-12. (In Russ.)Vaz-Silva J., Tavares R., Ferreira M. et al. Tissue specifi c localization of angiotensin-(1-7) and its receptor Mas in the uterus of ovariectomized rats // J. Mol. Histol. 2012;43(5):597–602.Vaz-Silva J., Tavares R., Ferreira M. et al. Tissue specifi c localization of angiotensin-(1-7) and its receptor Mas in the uterus of ovariectomized rats. J. Mol. Histol. 2012;43(5):597–602.Ищенко Л.С., Воропаева Е.Е., Казачкова Э.А. и др. Новая коронавирусная инфекция COVID-19 и репродуктивное здоровье женщин. Факты и предположения // Якутский медицинский журнал. 2022;2(78):96-101. DOI: 10.25789/YMJ.2022.77.25.Ishchenko L.S., Voropaeva E.E., Kazachkova E.A. et al. New coronavirus infection COVID-19 and women’s reproductive health. Facts and assumptions. Yakut Medical Journal. 2022;2(78):96-101. DOI: 10.25789/YMJ.2022.77.25. (In Russ.)Li R., Yin T., Fang F. et al. Potential risks of SARS-CoV-2 infection on reproductive health // Reprod. Biomed. Online. 2020;41(1):89-95. DOI: 10.1016/j.rbmo.2020.04.018.Li R., Yin T., Fang F. et al. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod. Biomed. Online. 2020;41(1):89-95. DOI: 10.1016/j.rbmo.2020.04.018.di Mascio D., Khalil A., Saccone G. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis // Am. J. Obstetr. Gynecol. MFM. 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107.di Mascio D., Khalil A., Saccone G. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am. J. Obstetr. Gynecol. MFM. 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107.Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections // Viruses. 2020;12(2):194. DOI: 10.3390/v12020194.Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12(2):194. DOI: 10.3390/v12020194.Ferrazzi E.M., Frigerio L., Cetin I. et al. COVID-19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome // Int. J. Gynaecol. Obstet. 2020;149(3):377-378. DOI: 10.1002/ijgo.13162.Ferrazzi E.M., Frigerio L., Cetin I. et al. COVID-19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome. Int. J. Gynaecol. Obstet. 2020;149(3):377-378. DOI:10.1002/ijgo.13162.Vaz-Silva J., Carneiro M.M., Ferreira M.C. et al. The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium // Reprod. Sci. 2009;16(3):247-256. DOI: 10.1177/1933719108327593.Vaz-Silva J., Carneiro M.M., Ferreira M.C. et al. The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium. Reprod. Sci. 2009;16(3):247-256. DOI: 10.1177/1933719108327593.Jing Y., Run-Qian L., Hao-Ran W. et al. Potential infl uence of COVID-19/ACE2 on the female reproductive system // Mol. Hum. Reprod. 2020;26(6):367-373. DOI: 10.1093/molehr/gaaa030.Jing Y., Run-Qian L., Hao-Ran W. et al. Potential infl uence of COVID-19/ACE2 on the female reproductive system. Mol. Hum. Reprod. 2020;26(6):367-373. DOI: 10.1093/molehr/gaaa030.Cree I.A., White V.A., Indave B.I., Lokuhetti D. Revising the WHO classifi cation: female genital tract tumours // Histopathology. 2020;76(1):151-156. DOI: 10.1111/his.13977.Cree I.A., White V.A., Indave B.I., Lokuhetti D. Revising the WHO classifi cation: female genital tract tumours. Histopathology. 2020;76(1):151-156. DOI: 10.1111/his.13977.Ahmed A., Li X., Shams M. et al. Localization of the angiotensin II and its receptor subtype expression in human endometrium and identifi cation of a novel high-affi nity angiotensin II binding site // J. Clin. Invest. 1995;96(2):848-857. DOI: 10.1172/JCI118131.Ahmed A., Li X., Shams M. et al. Localization of the angiotensin II and its receptor subtype expression in human endometrium and identifi cation of a novel high-affi nity angiotensin II binding site. J. Clin. Invest. 1995;96(2):848-857. DOI: 10.1172/JCI118131.Li X., Ahmed A. Expression of angiotensin II and its receptor subtypes in endometrial hyperplasia: a possible role in dysfunctional menstruation // Lab. Invest. 1996;75:137–145.Li X., Ahmed A. Expression of angiotensin II and its receptor subtypes in endometrial hyperplasia: a possible role in dysfunctional menstruation. Lab. Invest. 1996;75:137–145.Elenson L.H., Matias-Guiu X., Mutter G.L. Endometrial hyperplasia without atypia // WHO Classifi cation of Tumours. 5th ed. Female Genital Tumours / I.A. Cree, J. Ferlay, R. Jakob et al. (eds). Lyon: IARC Publications, 2020. P. 248–249.Elenson L.H., Matias-Guiu X., Mutter G.L. (2020). Endometrial hyperplasia without atypia. In I.A. Cree, J. Ferlay, R. Jakob et al. (eds). WHO Classifi cation of Tumours. 5th ed. Female Genital Tumours. Lyon: IARC Publications. P. 248–249.Lax S.F., Mutter G.L. Endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia // WHO Classifi cation of Tumours. 5th ed. Female Genital Tumours / I.A. Cree, J. Ferlay, R. Jakob et al.(eds). Lyon: IARC Publications, 2020. P. 250–251.Lax S.F., Mutter G.L. (2020). Endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia. In I.A. Cree, J. Ferlay, R. Jakob et al.(eds). WHO Classifi cation of Tumours. 5th ed. Female Genital Tumours. Lyon: IARC Publications. P. 250–251.Ferlay J., Soerjomataram I., Ervik M. et al. GLOBOCAN. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, 2012.Ferlay J., Soerjomataram I., Ervik M. et al. (2012). GLOBOCAN. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer.Пшукова Е.М., Гамаева Ф.Б., Мусукаева А.Б., Пшукова А.А. Рак эндометрия у разных возрастных групп пациентов: морфологические особенности // Медицина. Социология. Философия. Прикладные исследования. 2021;5:4-7.Pshukova Е.М., Gamaeva F.B., Musukaeva A.B., Pshukova A.A. Endometry cancer in diff eren age groups of patients: morphological features. Medicine. Sociology. Philosophy. Applied Research. 2021;5:4-7. (In Russ.)Солопова А., Идрисова Л., Чуканова Е. Рак эндометрия: возможности и перспективы реабилитации // Врач. 2018;29(10):12-14. DOI: 10.29296/25877305-2018-10-03.Solopova A., Idrisova L., Chukanova E. Endometrial cancer: opportunities and prospects of rehabilitation. Vrach. 2018;29(10):12-14. DOI: 10.29296/25877305-2018-10-03.Delforce S., Lumbers E., Corbisier de Meaultsart C. et al. Expression of renin-angiotensin system (RAS) components in endometrial cancer // Endocr. Connect. 2017;6(1):9-19. DOI: 10.1530/EC-16-0082.Delforce S., Lumbers E., Corbisier de Meaultsart C. et al. Expression of renin-angiotensin system (RAS) components in endometrial cancer. Endocr. Connect. 2017;6(1):9-19. DOI: 10.1530/EC-16-0082.Shibata K., Kikkawa F., Mizokami Y. et al. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma // Tumour Biol. 2005;26(1):9-16. DOI: 10.1159/000084181.Shibata K., Kikkawa F., Mizokami Y. et al. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. Tumour Biol. 2005;26(1):9-16. DOI: 10.1159/000084181.Watanabe Y., Shibata K., Kikkawa F. et al. Adipocytederived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system // Clin. Cancer Res. 2003;9(17):6497- 6503.Watanabe Y., Shibata K., Kikkawa F. et al. Adipocytederived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angio-tensin system. Clin. Cancer Res. 2003;9(17):6497- 6503.Vehar S., Boushra M., Ntiamaah P., Biehl M. Postacute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’ // Cleve. Clin. J. Med. 2021;88(5):267- 272. DOI:10.3949/ccjm.88a.21010Vehar S., Boushra M., Ntiamaah P., Biehl M. Post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘longhaulers’. Cleve. Clin. J. Med. 2021;88(5):267-272. DOI: 10.3949/ccjm.88a.21010Каратеев А.Е., Амирджанова В.Н., Насонов Е.Л. и др. «Постковидный синдром»: в центре внимания скелетно-мышечная боль // Научно-практическая ревматология. 2021;59(3):255-262. DOI: 10.47360/1995-4484-2021-255-262.Karateev A.E., Amirdzhanova V.N., Nasonov E.L. et al. “Post-COVID syndrome: The focus is on musculoskeletal pain. Rheumatology Science and Practice. 2021;59(3):255-262. DOI: 10.47360/1995-4484-2021-255-262.National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: managing the long-term eff ects of COVID-19. URL: www.nice.org.uk/guidance/ng188 (дата обращения 06.12.2023).National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: managing the long-term eff ects of COVID-19. URL: www.nice.org.uk/guidance/ng188 (accessed 06.12.2023).МКБ-10 – Международная классификация болезней 10-го пересмотра. Состояние после COVID-19 (U09). U09.9. Состояниепосле COVID-19 неуточненное. URL: https://mkb-10.com/index.php?pid=23014 (дата обращения 06.12.2023).ICD-10, 10th revision. Condition after COVID-19 (U09). U09.9. Post-COVID-19 condition, unspecifi ed. URL: https://mkb-10.com/index.php?pid=23014 (accessed 06.12.2023).Доклад о состоянии здравоохранения в Европе. Итоги реализации связанных со здоровьем Целей в области устойчивого развития в период пандемии COVID-19 с учетом принципа «никого не оставить без внимания» / Всемирная организация здравоохранения, Европейское региональное бюро. URL: https://www.who.int/europe/ru/data/9789289057608 (дата обращения: 06.12.2023).The European Health Report 2021: highlights. Taking stock of the health-related Sustainable Development Goals during the COVID-19 pandemic with a focus on leaving no one behind / World Health Organization. Europe. URL: https://www.who.int/europe/ru/data/9789289057608 (accessed: 06.12.2023).Li K., Chen G., Hou H. et al. Analysis of sex hormones and menstruation in COVID-19 women of child- bearing age //Reprod. Biomed. Online. 2021;42(1):260-267. DOI: 10.1016/j.rbmo.2020.09.020Li K., Chen G., Hou H. et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod. Biomed. Online. 2021;42(1):260-267. DOI: 10.1016/j.rbmo.2020.09.020Phelan N., Behan L.A., Owens L. The impact of the COVID-19 pandemic on women’s reproductive health // Front. Endocrinol. (Lausanne). 2021;12:642755. DOI: 10.3389/fendo.2021.642755.Phelan N., Behan L.A., Owens L. The impact of the COVID-19 pandemic on women’s reproductive health. Front. Endocrinol. (Lausanne). 2021;12:642755. DOI: 10.3389/fendo.2021.642755.Takmaz T., Gundogmus I., Okten S.B., Gunduz A. The impact of COVID-19-related mental health issues on menstrual cycle characteristics of female healthcare providers // J. Obstet. Gynaecol. Res. 2021;47(9):3241- 3249. DOI: 10.1111/jog.14900.Takmaz T., Gundogmus I., Okten S.B., Gunduz A. The impact of COVID-19-related mental health issues on menstrual cycle characteristics of female healthcare providers. J. Obstet. Gynaecol. Res. 2021;47(9):3241- 3249. DOI: 10.1111/jog.14900.Белокриницкая Т.Е., Фролова Н.И., Мудров В.А. и др. Постковидный синдром у женщин раннего репродуктивного возраста // Акушерство и гинекология. 2023;7:47-54 DOI: 10.18565/aig.2023.67Belokrinitskaya T.E., Frolova N.I., Mudrov V.A. et al. Post-COVID-19 syndrome in early reproductive age women. Obstetrics and Gynecology. 2023;7:47-54 DOI: 10.18565/aig.2023.67. (In Russ.)Wang S., Farland L.V., Gaskins A.J. et al. Association of laparoscopically-confi rmed endometriosis with long COVID-19: a prospective cohort study // Am. J. Obstet. Gynecol. 2023;228(6):714.e1-714.e13. DOI: 10.1016/j.ajog.2023.03.030.Wang S., Farland L.V., Gaskins A.J. et al. Association of laparoscopically-confi rmed endometriosis with long COVID-19: a prospective cohort study. Am. J. Obstet. Gynecol. 2023;228(6):714.e1-714.e13. DOI: 10.1016/j.ajog.2023.03.030.Subramanian A., Nirantharakumar K., Hughes S. et al. Symptoms and risk factors for long COVID in non-hospitalized adults // Nat. Med. 2022;28(8):1706-1714. DOI: 10.1038/s41591-022-01909-w.Subramanian A., Nirantharakumar K., Hughes S. et al. Symptoms and risk factors for long COVID in nonhospitalized adults. Nat. Med. 2022;28(8):1706-1714. DOI: 10.1038/s41591-022-01909-w.Казачков Е.Л., Затворницкая А.В., Воропаева Е.Е. и др. Особенности пролиферативной и антипролиферативной активности клеток эндометрия при его гиперплазии в сочетании с хроническим эндометритом // Акушерство и гинекология. 2019;8:100- 106. DOI: 10.18565/aig.2019.8.100-106.Kazachkov E.L., Zatvornitskaya A.V., Voropaeva Е.Е. et al. Characteristics of the proliferative and antiproliferative activities of the cells of the endometrium in its hyperplasia concurrent with chronic endometritis. Obstetrics and Gynecology. 2019;8:100-106. DOI: 10.18565/aig.2019.8.100-106. (In Russ.)Толибова Г.Х. Патогенетические детерминанты эндометриальной дисфункции у пациенток с миомой матки // Журнал акушерства и женских болезней. 2018;67(1):65-72. DOI: 10.17816/JOWD67165-72.Tolibova G.Kh. Pathogenetic determinants of endometrial dysfunction in patients with myoma. Journal of Obstetrics and Women’s Diseases. 2018;67(1):65-72. DOI: 10.17816/JOWD67165-72. (In Russ.)Оразов М.Р., Михалева Л.М., Семенов П.А. и др. Хронический эндометрит и контраверсии антибактериальной терапии // Трудный пациент. 2020;18(10):41- 46. DOI: 10.24411/2074-1995-2020-10072.Orazov M.R. Mikhaleva L.M., Semenov P.A. et al. Chronic endometritis and controversies of antibiotic therapy. Diffi cult Patient. 2020;18(10):41-46. DOI: 10.24411/2074-1995-2020-10072. (In Russ.)Гиперплазия эндометрия / Э.А. Казачкова, Е.Е. Воропаева, А.В. Затворницкая, Е.Л. Казачков. Челябинск: Титул, 2022. 224 с.Kazachkova E.A., Voropaeva Е.Е., Zatvornitskaya А.V., Kazachkov Е.L. (2022). Endometrial Hyperplasia. Chelyabinsk: Titul. 224 p. (In Russ.)Кузнецова И.В. Возможности терапии гиперпластических процессов эндометрия // Трудный пациент. 2010;8(1-2):18-22.Kuznetsova I.V. Possibilities for treating endometrial hyperplastic processes. Diffi cult Patient. 2010;8(1- 2):18-22. (In Russ.)Kimura F., Takebayashi A., Ishida M. et al. Chronic endometritis and its eff ect on reproduction. Review // J. Obstet. Gynaecol. Res. 2019; 45( 5):951-960.Kimura F., Takebayashi A., Ishida M. et al. Chronic endometritis and its eff ect on reproduction. Review. J. Obstet. Gynaecol. Res. 2019; 45( 5):951-960.Kuchler T., Günthner R., Ribeiro A. et al. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic infl ammation // Angiogenesis. 2023;26(4):547-563. DOI: 10.1007/s10456-023-09885-6.Kuchler T., Günthner R., Ribeiro A. et al. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic infl ammation. Angiogenesis. 2023;26(4):547-563. DOI: 10.1007/s10456-023-09885-6.Новиков В.Е., Левченкова О.С. Гипоксией индуцированный фактор (HIF-1α) как мишень фармакологического воздействия // Обзоры по клинической фармакологии и лекарственной терапии. 2013;11(2):8-16.Novikov V.Ye., Levchenkova O.S. Hypoxia-inducible factor as a pharmacological target. Reviews on Clinical Pharmacology and Drug Therapy. 2013;11(2):8-16. (In Russ.)Доброхотова Ю.Э., Сапрыкина Л.В., Чулкова О.В. Методы лечения атипической гиперплазии эндометрия // Лечебное дело. 2011;1:71-75.Dobrokhotova Yu.E., Saprykina L.V., Chulkova O.V. Methods of treatment for atypical endometrial hyperplasia. Journal of General Medicine. 2011;1:71-75. (In Russ.)Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments // Infect. Dis. (Lond). 2021;53(10):737-754. DOI: 10.1080/23744235.2021.1924397.Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. (Lond). 2021;53(10):737-754. DOI: 10.1080/23744235.2021.1924397.Yeoh Y.K., Zuo T., Lui G.C.Y. et al. Gut microbiota composition refl ects disease severity and dysfunctional immune responses in patients with COVID-19 // Gut. 2021;70(4):698–706. DOI: 10.1136/gutjnl-2020-323020.Yeoh Y.K., Zuo T., Lui G.C.Y. et al. Gut microbiota composition refl ects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698–706. DOI: 10.1136/gutjnl-2020-323020.Zuo T., Zhan H., Zhang F. et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge // Gastroenterology. 2020;159(4):1302-1310e5. DOI: 10.1053/j.gastro.2020.06.048.Zuo T., Zhan H., Zhang F. et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302-1310e5. DOI: 10.1053/j.gastro.2020.06.048.Zuo T., Zhang F., Lui G.C.Y. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization // Gastroenterology. 2020;159(3):944-955e8. DOI: 10.1053/j.gastro.2020.05.048.Zuo T., Zhang F., Lui G.C.Y. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944- 955e8. DOI: 10.1053/j.gastro.2020.05.048.Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19): Временные методические рекомендации. Версия 17 от 14.12.2022 / С.Н. Авдеев, Л. В. Адамян, Е.И. Алексеева и др. М.: Министерство здравоохранения Российской Федерации, 2022. 260 с.Avdeev S.N., Adamyan L.V., Alekseeva E.I. et al. (2022). Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection (COVID-19): Interim Guidelines. Version 17, 14.12.2022. Moscow: Ministry of Healthcare of the Russian Federation. 260 p. (In Russ.)Simões e Silva A.C., Silveira K.D., Ferreira A.J., T eixeira M.M. ACE2, angiotensin-(1-7) and Mas receptor axis in infl ammation and fi brosis // Br. J. Pharmacol. 2013;169(3):477-492. DOI: 10.1111/bph.12159.Simões e Silva A.C., Silveira K.D., Ferreira A.J., Teixeira M.M. ACE2, angiotensin-(1-7) and Mas receptor axis in infl ammation and fi brosis. Br. J. Pharmacol. 2013;169(3):477-492. DOI: 10.1111/bph.12159.Batlle D., Soler M.J., Ye M. ACE2 and diabetes: ACE of ACEs? // Diabetes. 2010;59(12):2994-2996. DOI: 10.2337/db10-1205.Batlle D.. Jose Soler M., Ye M. ACE2 and diabetes: ACE of ACEs? Diabetes. 2010;59(12):2994-2996. DOI: 10.2337/db10-1205.

The authors declare that there are no conflicts of interest present.